Smartleaf Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Smartleaf Asset Management's PCRX Position: Q3 2026 in Review
Smartleaf Asset Management increased its Pacira BioSciences (PCRX) stake by 32% in Q3 2026, buying an estimated $2.81K and bringing the position to 463 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2358.
Smartleaf Asset Management first reported a position in PCRX in Q2 2024 and has held it in 10 quarters since. The position peaked at $19.9K in Q4 2025. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Smartleaf Asset Management held 463 shares of Pacira BioSciences worth $11.9K as of Q3 2026.
- Smartleaf Asset Management bought 111 Pacira BioSciences shares in Q3 2026, an estimated $2.81K.
- Pacira BioSciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2358 holding.
- Smartleaf Asset Management first reported a position in Pacira BioSciences in Q2 2024 and has held it in 10 quarters since.
- Smartleaf Asset Management's Pacira BioSciences position peaked at $19.9K in Q4 2025.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.